BiomX (PHGE) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free PHGE Stock Alerts $0.35 +0.01 (+2.94%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBiomX Inc. (PHGE) Q4 2023 Earnings Call Transcriptseekingalpha.com - April 5 at 12:18 PMBiomX Inc. (AMEX:PHGE) Q4 2023 Earnings Call Transcriptmsn.com - April 4 at 11:15 AMBiomX’s Robust Financial Health and Promising Clinical Advancements Bolster Buy Ratingmarkets.businessinsider.com - April 4 at 6:14 AMAzitra stock slides on pricing stock offering to raise $5 millionmsn.com - February 14 at 11:16 PMBiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections on December 4, 2023finance.yahoo.com - November 30 at 6:57 PMWhy Is Bacterial Infection-Focused BiomX Stock Trading Lower Today?benzinga.com - November 29 at 1:27 PMBiomX mulls pivotal trial for antibacterial after Phase 1/2 data in cystic fibrosismsn.com - November 29 at 7:51 AMBiomX Announces Positive Results From Phase 1b/2a Study Of BX004 In Chronic Pulmonary Infectionsmarkets.businessinsider.com - November 29 at 7:51 AMBiomX: BX004 Phage Cocktail Part 2, Phase 1b/2a Clinical Results In Cystic Fibrosis Expected Any Dayseekingalpha.com - November 23 at 8:34 AMPromising Clinical Trials and Financial Stability Bolster BiomX’s Buy Rating: An Analysis by Michael Higginsmarkets.businessinsider.com - November 16 at 8:25 AMAnalysts Offer Insights on Healthcare Companies: BiomX (PHGE), Quoin Pharmaceuticals (QNRX) and Precigen (PGEN)markets.businessinsider.com - November 15 at 2:14 AMBiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the 37th Annual North American Cystic Fibrosis Conferencefinance.yahoo.com - October 27 at 8:57 AMBiomX Announces the Appointment of Edward L. Williams to its Board of Directorsfinance.yahoo.com - October 18 at 8:36 AMBiomX Announces Completion of Patient Dosing in Part 2 of the Phase 1b/2a Study Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosisfinance.yahoo.com - October 4 at 10:03 AMBiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the European Respiratory Society (ERS) International Congress 2023finance.yahoo.com - September 7 at 12:25 PMBiomX to Present at H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 4:53 PMBiomX Reports Second Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - August 9 at 8:54 AMBiomX to Host Second Quarter 2023 Financial Results Conference Call and Webcast on August 9th, 2023finance.yahoo.com - August 3 at 5:08 AMNYSE American Initiates Delisting Proceedings for BiomX Warrantsfinance.yahoo.com - June 8 at 6:09 PMBiomX Reports First Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - May 15 at 8:14 AMBiomX Announces the Appointments of Jason M. Marks and Michael E. Dambach to Board of Directorsfinance.yahoo.com - May 12 at 8:24 AMBiomX Announces Second Closing of $7.5 Million Private Placementfinance.yahoo.com - May 5 at 7:58 AMBiomX to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on March 29th, 2023finance.yahoo.com - March 27 at 7:55 AMWhy Is BiomX (PHGE) Stock Down 18% Today?msn.com - February 24 at 1:43 PMBrandon Toranzo Stands Atop Essex Countymsn.com - January 28 at 2:06 AMPhage Therapy Market 2023 Expected to Reach Significant Rate by 2028marketwatch.com - January 17 at 1:17 AMBacteriophage Market 2023 : Industry Scenario, Strategies, Growth Factors and Forecast to 2028marketwatch.com - January 12 at 6:56 PMMd. biotech Adaptive Phage Therapeutics advances fight to wipe out superbugs in cystic fibrosisbizjournals.com - January 12 at 6:56 PMWhy Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Sessionmsn.com - December 19 at 6:01 PMFull Spectrum hosts gala to raise money for LGBTQ centermsn.com - December 18 at 12:20 AMBiomX To Present at H.C. Wainwright 1st Annual Investor Conference on Bacteriophagefinance.yahoo.com - November 29 at 9:55 AMBiomX, Inc. (PHGE) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 12 at 8:50 AMBiomX Reports Third Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - November 9 at 9:08 AMBiomX to Host Third Quarter 2022 Financial Results Conference Call and Webcast on November 9, 2022finance.yahoo.com - November 2 at 5:22 PMZuckerberg is all in on the metaverse whether you like it or notmsn.com - October 26 at 10:08 PMWhy Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterdaymsn.com - October 6 at 4:16 AMPackers-Bears home opener weekend is stacked with Luke Combs, Train concerts, Oktoberfest at the Lorelei, igNight Market and pregame partiesmsn.com - September 14 at 1:17 PMBiomX To Present at H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 11 at 8:21 AMBiomX Inc. (PHGE)finance.yahoo.com - September 8 at 9:10 AMBiomX To Report First Part Of CF Trial Data In Septembernasdaq.com - September 2 at 10:47 AMBiomX Reports Second Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - August 10 at 10:12 AMBiomX Announces Publication in Cell of Research Demonstrating Proof-of-Concept Assessment of Orally Administered Phage Treatment in Preclinical Model of Inflammatory Bowel Diseasefinance.yahoo.com - August 4 at 1:18 PMShort Volatility Alert: BiomX Inc.msn.com - July 29 at 6:59 PMMicrobiome Therapeutics Market Analysis By Industry Size, Share, Revenue Growth, Development And Demand Forecast To 2029marketwatch.com - July 9 at 10:10 AMBiomX To Delist Its Shares From Trading On Tel Aviv Stock Exchangenasdaq.com - July 6 at 3:46 AMBiomX Announces Voluntary Delisting from the Tel Aviv Stock Exchangefinance.yahoo.com - July 6 at 3:46 AMBoehringer Ingelheim and BiomX Collaborate to Discover Inflammatory Bowel Disease Microbiome Biomarkersfinance.yahoo.com - June 28 at 7:22 AMBiomX begins dosing of BX004 in trial to treat respiratory infections in cystic fibrosis patientsseekingalpha.com - June 27 at 4:20 PMBruised investors focus on biotechs with drugs closer to marketmsn.com - June 27 at 9:40 AMBiomX Announces Dosing of the First Two Patients in Phase 1b/2a Study of BX004 for Treatment of Chronic Respiratory Infections in Patients with Cystic Fibrosisfinance.yahoo.com - June 27 at 8:21 AM Get BiomX News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. PHGE Media Mentions By Week PHGE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHGE News Sentiment▼1.000.32▲Average Medical News Sentiment PHGE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHGE Articles This Week▼10▲PHGE Articles Average Week Get BiomX News Delivered to You Automatically Sign up to receive the latest news and ratings for PHGE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: APTO News Today SRZN News Today SNTI News Today COEP News Today ONVO News Today SRNE News Today SRNEQ News Today EVAX News Today ZIVO News Today BCDA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:PHGE) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiomX Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
